3w5e

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
m (Protected "3w5e" [edit=sysop:move=sysop])
Line 1: Line 1:
-
'''Unreleased structure'''
+
{{STRUCTURE_3w5e| PDB=3w5e | SCENE= }}
 +
===Crystal structure of phosphodiesterase 4B in complex with compound 31e===
 +
{{ABSTRACT_PUBMED_23602400}}
-
The entry 3w5e is ON HOLD until Paper Publication
+
==Function==
 +
[[http://www.uniprot.org/uniprot/PDE4B_HUMAN PDE4B_HUMAN]] Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. May be involved in mediating central nervous system effects of therapeutic agents ranging from antidepressants to antiasthmatic and anti-inflammatory agents.<ref>PMID:10846163</ref> <ref>PMID:15003452</ref>
-
Authors: Takahashi, M., Hanzawa, H.
+
==About this Structure==
 +
[[3w5e]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3W5E OCA].
-
Description: Crystal structure of phosphodiesterase 4B in complex with compound 31e
+
==Reference==
 +
<ref group="xtra">PMID:023602400</ref><references group="xtra"/><references/>
 +
[[Category: 3',5'-cyclic-nucleotide phosphodiesterase]]
 +
[[Category: Homo sapiens]]
 +
[[Category: Hanzawa, H.]]
 +
[[Category: Takahashi, M.]]
 +
[[Category: Copd]]
 +
[[Category: Hydrolase-hydrolase inhibitor complex]]
 +
[[Category: Inhibitor]]
 +
[[Category: Phosphodiesterase]]

Revision as of 16:15, 19 June 2013

Template:STRUCTURE 3w5e

Contents

Crystal structure of phosphodiesterase 4B in complex with compound 31e

Template:ABSTRACT PUBMED 23602400

Function

[PDE4B_HUMAN] Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. May be involved in mediating central nervous system effects of therapeutic agents ranging from antidepressants to antiasthmatic and anti-inflammatory agents.[1] [2]

About this Structure

3w5e is a 2 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

  • Goto T, Shiina A, Yoshino T, Mizukami K, Hirahara K, Suzuki O, Sogawa Y, Takahashi T, Mikkaichi T, Nakao N, Takahashi M, Hasegawa M, Sasaki S. Identification of the fused bicyclic 4-amino-2-phenylpyrimidine derivatives as novel and potent PDE4 inhibitors. Bioorg Med Chem Lett. 2013 Jun 1;23(11):3325-8. doi: 10.1016/j.bmcl.2013.03.104. , Epub 2013 Apr 4. PMID:23602400 doi:10.1016/j.bmcl.2013.03.104
  1. ↑ Xu RX, Hassell AM, Vanderwall D, Lambert MH, Holmes WD, Luther MA, Rocque WJ, Milburn MV, Zhao Y, Ke H, Nolte RT. Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity. Science. 2000 Jun 9;288(5472):1822-5. PMID:10846163
  2. ↑ Xu RX, Rocque WJ, Lambert MH, Vanderwall DE, Luther MA, Nolte RT. Crystal structures of the catalytic domain of phosphodiesterase 4B complexed with AMP, 8-Br-AMP, and rolipram. J Mol Biol. 2004 Mar 19;337(2):355-65. PMID:15003452 doi:http://dx.doi.org/10.1016/j.jmb.2004.01.040

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/3w5e"
Personal tools